Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis

被引:4511
作者
El-Serag, Hashem B. [1 ]
Rudolph, Lenhard
机构
[1] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Ctr Qual Care & Utilizat Studies, Houston, TX USA
[4] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
关键词
D O I
10.1053/j.gastro.2007.04.061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. HCC has several interesting epidemiologic features including dynamic temporal trends; marked variations among geographic regions, racial and ethnic groups, and between men and women; and the presence of several well-documented environmental potentially preventable risk factors. Moreover, there is a growing understanding on the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage. A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC ultimately could improve our current concepts for screening and treatment of this disease.
引用
收藏
页码:2557 / 2576
页数:20
相关论文
共 184 条
  • [41] Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
    Delhaye, M
    Louis, H
    Degraef, C
    LeMoine, O
    Deviere, J
    Gulbis, B
    Jacobovitz, D
    Adler, M
    Galand, P
    [J]. HEPATOLOGY, 1996, 23 (05) : 1003 - 1011
  • [42] CELLULAR ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA REQUIRES BINDING TO THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR TYPE-II RECEPTOR
    DENNIS, PA
    RIFKIN, DB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) : 580 - 584
  • [43] Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
    Di Micco, Raffaella
    Fumagalli, Marzia
    Cicalese, Angelo
    Piccinin, Sara
    Gasparini, Patrizia
    Luise, Chiara
    Schurra, Catherine
    Garre, Massimiliano
    Nuciforo, Paolo Giovanni
    Bensimon, Aaron
    Maestro, Roberta
    Pelicci, Pier Giuseppe
    di Fagagna, Fabrizio d'Adda
    [J]. NATURE, 2006, 444 (7119) : 638 - 642
  • [44] Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma
    Djojosubroto, MW
    Chin, AC
    Go, N
    Schaetzlein, S
    Manns, MP
    Gryaznov, S
    Harley, CB
    Rudolph, KL
    [J]. HEPATOLOGY, 2005, 42 (05) : 1127 - 1136
  • [45] Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women
    Donato, F
    Tagger, A
    Gelatti, U
    Parrinello, G
    Boffetta, P
    Albertini, A
    Decarli, A
    Trevisi, P
    Ribero, ML
    Martelli, C
    Porru, S
    Nardi, G
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (04) : 323 - 331
  • [46] The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
    El-Serag, H
    Davila, JA
    Petersen, NJ
    McGlynn, KA
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) : 817 - 823
  • [47] Risk factors for the rising rates of primary liver cancer in the United States
    El-Serag, HB
    Mason, AC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) : 3227 - 3230
  • [48] The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
    El-Serag, HB
    Hampel, H
    Javadi, F
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) : 369 - 380
  • [49] Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
    El-Serag, HB
    Tran, T
    Everhart, JE
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 460 - 468
  • [50] Hepatocellular carcinoma: Recent trends in the United States
    El-Serag, HB
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S27 - S34